###begin article-title 0
###xml 88 93 <span type="species:ncbi:9606">human</span>
Chordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesis
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 596 601 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
Pericytes play a specialized role in regulating angiogenesis and vascular function by providing vascular stability and controlling endothelial cell proliferation. Disorders in pericyte function and pericyte-endothelial interaction have been observed in several disease states including tumor angiogenesis and diabetic microangiopathy. In ischemic retinal disease, hypoxia is a potent driver of retinal angiogenesis. This study investigated the effects of hypoxia on retinal pericyte gene expression, and demonstrates a role in angiogenesis regulation for the hypoxia driven gene, chordin-like 1 (CHL-1).
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 357 362 <span type="species:ncbi:9606">human</span>
In the current studies, we investigated hypoxia-induced gene expression in human retinal pericytes and found that expression of CHL-1, a member of the bone morphogenetic protein (BMP) superfamily, is upregulated by hypoxia. We investigated regulation of CHL-1 expression and the ability of CHL-1 to antagonize the antiangiogenic properties of BMP-4 using a human cell-based angiogenesis assay.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 131 136 <span type="species:ncbi:9606">human</span>
We report that hypoxia induced hypoxia inducible factor-1alpha-driven expression of CHL-1. Both CHL-1 and BMP-4 were secreted from human retinal pericytes. We found that CHL-1 complexes with BMP-4 to antagonize the antiangiogenic effects of BMP-4, and that BMP-4 and vascular endothelial growth factor (VEGF) co-regulate angiogenesis.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
We propose that hypoxia-induced upregulation of CHL-1 alters the homeostatic balance between BMP-4 and VEGF to synergize with VEGF in driving retinal angiogenesis.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
Diabetic retinopathy is a microvascular complication of both Type 1 and Type 2 diabetes and is characterized by increased tissue ischemia, angiogenesis, and permeability. This microvascular disease is a major cause of blindness in the working age population [1]. The development of diabetic retinopathy reflects the convergence of hemodynamic and metabolic insults, including hyperglycemia, in susceptible individuals.
###end p 11
###begin p 12
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
Vascular endothelial growth factor (VEGF) is known to be induced by hypoxia and may mediate hypoxia-induced angiogenesis [2]. VEGF alone is sufficient to produce many of the vascular abnormalities common to diabetic retinopathy and other ischemic retinopathies, such as hemorrhage, edema, venous beading, capillary occlusion with ischemia, microaneurysm formation, and intraretinal vascular proliferation [3].
###end p 12
###begin p 13
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 318 319 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 584 585 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
Retinal pericytes are smooth muscle-like cells with attenuated processes enveloping the abluminal surface of microvessels and sharing a common basement membrane with the underlying endothelium (reviewed in [4]). Pericytes express alpha-smooth muscle actin and have thus been implicated to have a contractile function [5]. They are proposed to regulate microvascular angiogenesis and synthesize components of the vascular basement membrane [6,7]. Pericytes have been demonstrated to be involved in the regulation of endothelial cell number and morphology and microvessel architecture [8].
###end p 13
###begin p 14
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 334 335 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 487 489 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 149 154 <span type="species:ncbi:9606">human</span>
###xml 538 543 <span type="species:ncbi:9606">human</span>
In this study we present novel findings that chordin-like 1 (CHL-1), a bone morphogenetic protein (BMP) antagonist [9], is upregulated by hypoxia in human retinal pericytes, and that its expression is driven by hypoxia inducible factor-1alpha (HIF-1alpha). CHL-1 has previously been reported to be expressed in the developing retina [9], but has not yet been associated with diabetic or ischemic retinopathy. BMP-4 has been implicated in angiogenesis through a VEGF-dependent mechanism [10]. We therefore propose that CHL-1 expression by human retinal pericytes in response to hypoxia may play an important role in regulating retinal angiogenesis through modulation of BMP-4 actions on endothelial cells.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Cell culture and hypoxia
###end title 16
###begin p 17
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 255 261 <span type="species:ncbi:9913">bovine</span>
###xml 511 517 <span type="species:ncbi:9913">bovine</span>
###xml 719 725 <span type="species:ncbi:9913">bovine</span>
Primary cultures of human retinal pericytes (hRPC) were obtained from Cambrex (Nottingham, UK) and were cultured in  medium (Invitrogen, Paisley, Scotland) supplemented with 2 mM L-glutamine 50 U/ml penicillin, 50 mug/ml streptomycin, and 10% (v/v) fetal bovine serum. For experiments, cells were used at passage four or less and maintained in medium with 10% serum. HeLa (LGC promochem, Teddington, UK) cells were cultured in minimum essential medium (Sigma, Dublin, Ireland) supplemented with 10% (v/v) fetal bovine serum, 2 mM L-glutamine, 50 U/ml penicillin, 50 mug/ml streptomycin, and non-essential amino acids (Sigma). Cos7 (LGC Promochem) cells were cultured in DMEM (Cambrex) supplemented with 10% (v/v) fetal bovine serum, 2 mM L-glutamine, 50 U/ml penicillin, and 50 mug/ml streptomycin.
###end p 17
###begin p 18
###xml 178 179 178 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 190 191 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 210 211 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 272 273 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
For hypoxia experiments, cells were placed in an hypoxia chamber (Coy Laboratories, Grass Lake, MI) allowing the establishment of humidified, ambient, atmospheric hypoxia of 1% O2 with 5% CO2 and a balance of N2. Temperature was maintained at 37 degreesC. Extracellular pO2 measurements were made by using fluorescence quenching oxymetry (Oxylite-2000; Oxford Optronix, Oxford, UK).
###end p 18
###begin title 19
RNA extraction and cDNA synthesis
###end title 19
###begin p 20
RNA was extracted from hRPC using RNeasy kit (Qiagen, Crawley, UK) according to the manufacturer's instructions. RT-PCR was performed as follows: 2 mug of total RNA was treated with DNaseI (Invitrogen), according to the manufacturer's instructions, to remove chromosomal DNA. Reverse transcription was performed using random primer (Invitrogen) and Superscript II (Invitrogen) using the manufacturer's protocol.
###end p 20
###begin p 21
###xml 111 118 111 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
Limited cycle PCR was performed using the following primers, designed using the Primer3 software described in (Table 1) [11].
###end p 21
###begin title 22
Limited cycle and real time PCR primers
###end title 22
###begin p 23
Limited cycle PCR was performed using primers, designed using  software [11]. For real-time, PCR probes were labeled with 5'-FAM and 3'-TAMRA as quencher with the exception of the ribosomal probe, which was labeled with 5'-VIC to facilitate multiplexing.
###end p 23
###begin title 24
Real-time (Taqman) polymerase chain reaction
###end title 24
###begin p 25
###xml 218 225 218 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
Real-time (Taqman) polymerase chain reaction transcript levels were determined by real-time PCR using a PerkinElmer 7700 analyzer (Perkin Elmer Life Sciences, Shelton, CT). Probe and primer sequences were described in Table 1. Probes were labeled with 5'-FAM and 3'-TAMRA as quencher with the exception of the ribosomal probe, which was labeled with 5'-VIC to facilitate multiplexing. All results were normalized to 18S rRNA (pre-developed assay reagent, PerkinElmer Life Sciences).
###end p 25
###begin title 26
Gene microarray analysis
###end title 26
###begin p 27
RNA isolation was performed as described in the previous section. In vitro transcription and microarray analysis were performed as follows: 5 mug of total RNA were annealed to 100 pmol of the T7-(dT)24 primer. Then first-strand cDNA synthesis was completed by incubating the mixture with 1 mul of Superscript II RT (200 units) at 42 degreesC for 1 h. Second-strand synthesis was performed in a total volume of 150 mul. Following purification, the cDNA was extracted with phenol chloroform, precipitated with ammonium acetate, and resuspended in RNase-free water. Synthesis of cRNA was performed by in vitro transcription. The amplified cRNA was purified with an affinity resin column. Biotin-labeled cRNA prepared from template cDNAs was fragmented and hybridized to the HG U133A array (Affymetrix, High Wycombe, UK). Arrays were then washed and fluorescently labeled before being scanned using a confocal scanner. Microarray Suite 5.1 software (Affymetrix) was used to analyze the relative abundance of each gene from the average difference of fluorescent intensities. Calculated signal/log ratios for each gene at all time points of hypoxia were compared to normoxia, and those genes with a value greater than 0.6 or less than -0.6 (1.5 fold difference) in all three biologic replicate experiments were examined further.
###end p 27
###begin title 28
Cloning of the chordin-like 1 promoter and open reading frame
###end title 28
###begin p 29
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 130 135 <span type="species:ncbi:9606">human</span>
A 1537 bp fragment of the CHL-1 promoter was amplified using the Advantage2 PCR enzyme system (BD Biosciences, Oxford, UK) from a human genomic library EMBL3 SP6/T7 (HL 1067 J, BD Biosciences) with the following primers, sense 5'-GGA GAT AAC AAC CAG AGA GTA GTG G-3' and, antisense 5'-GAA AAG GAG GTG AGG GAA GC-3'. The PCR product was immediately cloned into the TA cloning vector pCRII-TOPO (Invitrogen). The plasmid was restricted using the enzymes Kpn1 (NEB) and Xho1 (NEB), the resulting promoter fragment was subcloned into the reporter vector pGL3 Basic (Promega Southampton, UK).
###end p 29
###begin p 30
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 108 113 <span type="species:ncbi:9606">human</span>
The open reading frame of CHL-1 was amplified using the Advantage2 PCR enzyme system (BD Biosciences) using human retinal pericyte cDNA as a template. A sense primer with a BamH1 site, 5'-GCT CGG ATC CGC CTG TCA CCT TTT GCA GTG GTC-3', and an antisense primer with an EcoR1 site, 5'-TGC AGA ATT CGC TTA CAG TGG CCC TTT TCA GAT C-3', were used to generate CHL-1 expression from a parent vector, pcDNA6/V5-His C (Invitrogen), designated pcDNA6 CHL-1/V5-His.
###end p 30
###begin title 31
Overexpression of hypoxia inducible factor-1alpha
###end title 31
###begin p 32
###xml 261 263 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
Wild-type (WT) and double mutant (DM) constructs expressing HIF-1alpha were a gift from Thilo Hagen (University College London, London, UK). Prolines 564 and 402 were mutated to alanine, as these are the residues important for targeted degradation in normoxia [12]. Pericytes were transfected, according to manufacturer's protocol, with 4 microg of each construct using 12 microl Fugene 6 (Roche, Dublin, Ireland). After 24 h following transfection, the medium was changed and the cells were incubated for a further 24 h. RNA was then isolated and analyzed by RT-PCR, or nuclear protein extracts were examined by western blot analysis to detect HIF-1alpha protein.
###end p 32
###begin title 33
Luciferase assays
###end title 33
###begin p 34
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
HeLa cells were transfected with plasmids pGL3-CHL-1 or pGL3-HRE [13] along with DM-HIF-1alpha, using 6 microl Fugene 6 (Roche). Cells were transfected for 24 h, medium replaced with fresh and incubated for a further 24 h. Cells transfected with DM-HIF-1alpha were incubated in normoxia, and cells transfected without DM-HIF-1alpha were incubated in hypoxia. Luciferase gene reporter assay was performed according to the manufacturer's instructions (Promega).
###end p 34
###begin title 35
Analysis of chordin-like 1 and bone morphogenetic protein -4 complex formation
###end title 35
###begin p 36
###xml 521 522 501 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 524 525 504 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 647 648 627 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 650 651 630 631 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 790 791 770 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 793 794 773 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Cos7 cells were transfected as described previously with either empty vector, pcDNA/V5-HisC, or with the CHL-1 expression vector, pcDNA6 CHL-1/V5-His. Cells were lysed, and whole cell extracts were made. Next, 50 microl of extract was incubated with 250 ng rhBMP-4 (R&D Systems, Abingdon, UK) for 1 h at 4 degreesC before incubation with 100 microl Ni-NTA magnetic beads, overnight at 4 degreesC with constant rocking. Ni-NTA magnetic beads had been previously washed with binding buffer, pH 8.0, that contained 50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, and 0.05% Tween 20. Complexes were washed in wash buffer, pH 8.0, that contained 50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, and 0.05% Tween 20, and eluted off the magnetic beads with elution buffer, pH 8.0, that contained 50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, and 0.05% Tween 20. Samples were electrophoresed on SDS-PAGE gels, transferred to PVDF membranes, and probed for either V5-tagged CHL-1 or BMP-4.
###end p 36
###begin title 37
###xml 32 37 <span type="species:ncbi:9606">human</span>
Differential gene expression in human retinal pericytes exposed to hypoxia.
###end title 37
###begin p 38
###xml 32 37 <span type="species:ncbi:9606">human</span>
The transcriptional response of human retinal pericytes to hypoxia was examined by microarray analysis, the SLR (signal-log ratio) is the mean value of three independent experiments.
###end p 38
###begin title 39
Western blot analysis
###end title 39
###begin p 40
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
Western blot analysis was performed by standard procedures [14]. HIF-1alpha protein levels were detected using a 1:500 dilution of either anti-HIF-1alpha (Biomol) or anti-HIF-1alpha antibody (AbCam, Canbridge, UK). V5-tagged CHL-1 was detected using a 1:5000 dilution of the anti-V5 antibody (Invitrogen). BMP-2 and BMP-4 was detected using 1:500 dilutions of the anti-BMP-2 and anti-BMP-4 antibodies (R&D Systems). CHL-1 was detected using a 1:1000 dilution of anti-CHL-1 antibody (R&D Systems).
###end p 40
###begin title 41
Angiogenesis assay
###end title 41
###begin p 42
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 279 284 <span type="species:ncbi:9606">human</span>
Human umbilical vascular endothelial cells and human diploid fibroblasts were obtained (day 1) as cocultures in 24 well plates (AngioKit, TCS CellWorks Ltd., Buckingham, UK). Medium, with treatments or vehicle, was replenished on days 1, 4, 7, and 9. Treatments were recombinant human BMP-2, BMP-4, and CHL-1 (R&D Systems). In addition, 2 ng/ml VEGF and 20 muM Suramin (TCS Cellworks) were used as positive and negative controls respectively. Tubule formation was examined at day 11. Cells were fixed with ice-cold 70% ethanol and tubules were quantitated and visualized following fixing and staining for CD31 platelet-endothelial cell adhesion molecule 1 (PECAM-1) using a combined ELISA and histology kit (TCS CellWorks Ltd., UK) according to the manufacturer's instructions. Angiogenesis was quantitated by using anti-CD31 antibody coupled to a soluble substrate, rho-nitrophenol phosphate, which permits quantitation by an optical density measurement. Plates were subsequently washed and stained using an insoluble substrate, 5-Bromo-4-chloro-3-indolyl phosphate (BCIP)/Nitroblue tetrazolium (NBT), for tubule visualization.
###end p 42
###begin title 43
Statistical analysis
###end title 43
###begin p 44
###xml 159 160 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Each result was representative of at least three independent experiments. All values are represented as the mean +/-standard error of measurement. The Student t-test was used to determine statistical differences. Significance of results was indicated when p<0.05.
###end p 44
###begin title 45
Results
###end title 45
###begin title 46
###xml 34 39 <span type="species:ncbi:9606">human</span>
Upregulation of chordin-like 1 in human retinal pericytes in response to hypoxia
###end title 46
###begin p 47
###xml 149 156 149 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 307 308 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 380 381 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 429 430 425 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 31 36 <span type="species:ncbi:9606">human</span>
The transcriptomic response of human retinal pericytes to hypoxia was examined. The mean signal-log ratio of three independent experiments is shown (Table 2). Using oxygen quenching oxymetry, we determined extracellular oxygen tensions at the level of the monolayer. Cells cultured in normoxia had a mean pO2 measurement of 140+/-2.79 mmHg, cells cultured in hypoxia had a mean pO2 measurement of 2.12+/-0.94 mmHg. The ambient pO2 in the hypoxia chamber was 6.21+/-0.08 mmHg (data not shown).
###end p 47
###begin p 48
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 486 487 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 563 567 563 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 699 703 699 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cox2</italic>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 804 808 804 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cox2</italic>
###xml 966 971 966 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 1180 1181 1180 1181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1184 1189 1184 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 1237 1246 1237 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 1253 1257 1253 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 1262 1267 1262 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cox 2</italic>
###xml 1316 1327 1316 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B,C</xref>
CHL-1 (upregulated gene number 20) is a novel gene not previously associated with diabetic retinopathy [9,15,16]. CHL-1 was upregulated in pericytes by hypoxia with a mean SLR of 0.9, corresponding to a 1.9 fold increase in expression (p<0.001). Two genes previously known to be associated with diabetic retinopathy were also upregulated: VEGF (upregulated gene number 7) is implicated in diabetic retinopathy, contributing to endothelial proliferation, permeability, and angiogenesis [2], and is known to be upregulated in pericytes in response to hypoxia [17]. VEGF was upregulated in pericytes by hypoxia with a mean SLR of 1.26, corresponding to a 2.4 fold increase in expression (p<0.001), and Cox2 (upregulated gene number 2) is associated with neovascularisation in models of retinopathy [18,19]. Cox2 was upregulated in pericytes by hypoxia with a mean SLR of 1.43, corresponding to a 2.7 fold increase in expression (p<0.05). To examine the upregulation of CHL-1 along with genes known to be upregulated in diabetic retinopathy, we performed real-time quantitative PCR. As determined by quantitative PCR over a time course (0, 6, 24 and 48 h) of exposure to hypoxia (1% O2), CHL-1 mRNA was upregulated 1.7 fold by 48 h (p<0.05; Figure 1A), and VEGF and Cox 2 mRNAs were upregulated twofold by 48 h (p<0.05; Figure 1B,C).
###end p 48
###begin p 49
###xml 554 555 552 553 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 557 562 555 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 570 571 568 569 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 573 577 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 589 590 587 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 592 597 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cox 2</italic>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 242 247 <span type="species:ncbi:9606">human</span>
Validation of three genes differentially expressed in human retinal pericytes (hRPC) in response to hypoxia. The upregulation of a selection of genes was validated with real time PCR, using a PerkinElmer 7700 analyzer, on cDNA generated from human retinal pericytes exposed to increasing periods of hypoxia (0, 6, 24, and 48 h). All results were normalized to 18S rRNA, using a pre-developed assay reagent. Data are expressed as mean relative quantity of mRNA, relative to control, for three independent experiments +/-standard error of measurement for (A) CHL-1 mRNA, (B) VEGF mRNA, and (C) Cox 2 mRNA. Data are expressed as mean+/-SEM values. The asterisk indicates a significance at p<0.05 and the double asterisk indicates a significance at p<0.001.
###end p 49
###begin title 50
Chordin-like 1 expression is directly transactivated by hypoxia inducible factor-1alpha
###end title 50
###begin p 51
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 338 340 338 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
The upstream region of CHL-1 was identified using the  Gateway at the UCSC interface. A 1537 bp fragment of the CHL-1 promoter was cloned, sequenced and inserted into the reporter vector pGL3 Basic (Promega), and named pGL3 CHL-1. Bioinformatic analysis of transcription factors binding to this region of the promoter was performed using TM software, and a putative HIF-1alpha binding site was located in the proximal promoter (data not shown).
###end p 51
###begin p 52
###xml 44 45 44 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 252 261 248 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human retinal pericytes were exposed to 1% O2 for 0, 6, 24, and 48 h. Nuclear and cytosolic extracts were prepared and used for western blotting. HIF-1alpha protein expression was dramatically increased by 6 h of hypoxia and remained elevated by 48 h (Figure 2A).
###end p 52
###begin p 53
###xml 88 89 84 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 291 292 283 284 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 782 783 758 759 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 798 803 774 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 884 889 856 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 1097 1098 1067 1068 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1178 1183 1148 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 1424 1425 1382 1383 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 148 153 <span type="species:ncbi:9606">human</span>
###xml 310 315 <span type="species:ncbi:9606">human</span>
HIF-1alpha drives expression of chordin-like 1 in retinal pericytes exposed to hypoxia. A: western blot analysis of nuclear extracts generated from human retinal pericytes exposed to increasing periods of hypoxia (0, 6, 24, and 48 h) for HIF-1alpha shows upregulation of the protein by 6 h. B: Transfection of human retinal pericytes maintained in normoxia with expression vectors for HIF-1 alpha, C is control/empty vector, WT is wild type vector, WT-HIF-1 alpha, DM is double mutant vector, DM-HIF-1 alpha, using the transfection reagent Fugene6, induces expression of many of the genes upregulated in response to hypoxia, as measured by RT-PCR. 18S PCR is shown as a loading control and western blot analysis confirmed expression from each of the HIF-1alpha expressing plasmids. C: Induction of CHL-1 mRNA in response to HIF-1alpha overexpression was quantitated by real time PCR. CHL-1 levels were normalized to 18S rRNA, using a pre-developed assay reagent. Data are expressed as mean relative quantity of mRNA, to control, for three independent experiments +/-standard error of measurement. D: HeLa cells were transfected, using the transfection reagent Fugene6, with the CHL-1 promoter or a luciferase reporter construct containing four HIF-1alpha responsive elements (HRE), alone (control), cotransfected with the HIF-1alpha expression vector DM-HIF-1alpha, or alone and subsequent exposure to hypoxia for 24 h (1% O2). Cotransfection with DM-HIF-1alpha as well as exposure to hypoxia induced activation of the CHL-1 promoter and the HRE construct. Data are expressed as mean+/-SEM values. The asterisk indicates a significance at p<0.05 and the double asterisk indicates a significance at p<0.001.
###end p 53
###begin p 54
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 313 317 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 322 326 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cox2</italic>
###xml 369 374 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 438 447 422 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B</xref>
###xml 520 528 500 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 543 548 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 641 650 621 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2C</xref>
###xml 717 726 693 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B</xref>
To determine if the CHL-1 promoter with the putative HIF-1alpha binding sequences was truly HIF-1alpha responsive, we transfected WT and DM constructs expressing HIF-1alpha into retinal pericytes. Semiquantitative RT-PCR was performed on RNA isolated from these cells for genes known to be HIF-1alpha responsive, VEGF and Cox2, and for the novel hypoxia regulated gene CHL-1. In addition, 18S rRNA PCR was performed as a loading control (Figure 2B). Expression of the transiently transfected HIF-1alpha is also shown in Figure 2. The level of CHL-1 mRNA expression in these transiently transfected cells was quantitated using real-time PCR (Figure 2C). Overexpression of HIF-1alpha was confirmed by western blotting (Figure 2B).
###end p 54
###begin p 55
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 144 145 140 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 389 394 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 701 710 685 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2D</xref>
To further determine the response of the CHL-1 promoter to HIF-1alpha, we transfected HeLa cells with pGL3 CHL-1 and either stimulated with 1% O2 or transfected with pGL3 CHL-1 and DM-HIF-1alpha. As a control, the experiment was also performed using a promoter reporter construct containing four hypoxia responsive elements driving the luciferase gene, HRE-Luc, instead of pGL3 CHL-1. The CHL-1 promoter was driven greater than threefold by HIF-1alpha (p<0.05) and greater than twofold by hypoxia (p<0.05). The control promoter reporter construct, which contains four hypoxia responsive elements (HREs) was driven greater than fourfold by HIF-1alpha and greater than sixfold by hypoxia (both p<0.001; Figure 2D).
###end p 55
###begin title 56
###xml 28 33 <span type="species:ncbi:9606">human</span>
Chordin-like 1 expressed in human retinal pericytes is secreted and binds to bone morphogenetic protein-4
###end title 56
###begin p 57
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 70 79 70 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C</xref>
###xml 429 438 428 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 503 505 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 518 519 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 669 678 668 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
###xml 754 763 753 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3C</xref>
CHL-1 mRNA was expressed in response to hypoxia in retinal pericytes (Figure 1C). The protein sequence for CHL-1 contained a signal peptide. Conditioned media (20 mul) from retinal pericytes exposed to hypoxia was examined by western blotting for secretion of CHL-1 using an anti-CHL-1 antibody (R&D Systems). Secreted CHL-1 was detectable in the conditioned media and was upregulated by hypoxia, correlating with the mRNA data (Figure 3A). CHL-1 is a BMP antagonist and previously shown to bind BMP-2 [20] and BMP-4 [9]. We investigated the expression of both these BMPs in retinal pericytes in response to normoxia and hypoxia. Both were expressed at the mRNA level (Figure 3B) and were secreted into the culture media as detected by western blotting (Figure 3C). Exposure to hypoxia had no significant expression on either BMP-2 or BMP-4 expression.
###end p 57
###begin p 58
###xml 107 108 107 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 153 154 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 263 264 263 264 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 269 270 269 270 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 472 473 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 495 497 495 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D:</bold>
###xml 863 865 863 865 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E:</bold>
###xml 28 33 <span type="species:ncbi:9606">human</span>
Chordin-like 1 expressed in human retinal pericytes is secreted and binds to bone morphogenetic protein-4. A: Conditioned media from HRPC exposed to 1% O2 for 24 and 48 h was examined by western blot analysis for secretion of CHL-1, using an anti-CHL-1 antibody. B and C: BMP-2 and BMP-4 expression in HRPC was examined in cells cultured in normoxia (N) and hypoxia (H) by RT-PCR (B) and secreted BMP2 and BMP-4 were detected in conditioned media from HRPC exposed to 1% O2 for 24 and 48 h (C). D: Transfection of the expression vector pcDNA6/CHL-1 V5-His into Cos7 cells, using the transfection reagent Fugene 6, resulted in expression of an approximately 60 kDa protein, which was detectable using an anti-V5 antibody. Cells were transfected with either an empty vector (E), pcDNA6/V5-His C, or a V5 tagged CHL-1 expressing vector (CHL-1), pcDNA6/CHL-1 V5-His. E: Whole cell extracts from Cos7 cells were transfected, using the transfection reagent Fugene 6, with empty pcDNA6/V5His (E), or with the expression vector pcDNA6 CHL-1/V5His (CHL-1) expressing V5His tagged CHL-1, were incubated with 250 ng rhBMP-4 and 100 ml NiNTA magnetic beads at 4 degreesC overnight. The complexes were washed, the beads and examined by western blotting for the presence of CHL-1, using anti-V5 antibody, and BMP-4, using an anti-BMP-4 antibody.
###end p 58
###begin p 59
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 452 461 452 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3D</xref>
###xml 1297 1305 1291 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
The open reading frame of CHL-1 was cloned and sequenced, and inserted inframe with the COOH-terminal V5 6xHis tag in the expression vector pcDNA6/V5His, and named pcDNA6 CHL-1/V5His. Cos7 cells were transfected with empty pcDNA6V5His (E), or with the expression vector pcDNA6 CHL-1/V5His (CHL-1) expressing V5His tagged CHL-1. Whole cell extracts were examined by western blotting for V5 tagged CHL-1 expression using an anti-V5 antibody (Invitrogen; Figure 3D) Whole cell extracts from Cos7 cells transfected with empty pcDNA6/V5His (E), or with the expression vector pcDNA6 CHL-1/V5His (CHL-1) expressing V5His tagged CHL-1, were incubated with 250 ng rhBMP-4 (R&D Systems) and 100 ml NiNTA magnetic beads at 4 degreesC overnight with rotation. The interaction of the two proteins was demonstrated by pulling down any complexes formed with the tagged CHL-1 using NiNTA magnetic beads (Qiagen) which bound the 6xHis tag on the expressed CHL-1. Proteins bound in a complex to CHl-1 were washed with wash buffer and then eluted using elution buffer. Western blotting was used to identify eluted proteins. CHl-1 was detected using anti-V5 antibody (Invitrogen), and BMP-4, using an anti-BMP-4 antibody (R&D Systems). The complexes bound to the Ni-NTA magnetic beads contained both CHL-1 and BMP-4 (Figure 3E).
###end p 59
###begin title 60
Bone morphogenetic protein-4 inhibits angiogenesis and is antagonized by chordin-like 1
###end title 60
###begin p 61
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 516 527 515 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4A,D</xref>
###xml 702 713 701 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5B,D</xref>
###xml 812 823 811 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4C,D</xref>
BMPs have been previously reported to be negative growth regulators in the adult retinal pigmented epithelium [21], and, more specifically, BMP-4 has been demonstrated to mediate apoptosis of capillary endothelial cells [22]. We wanted to determine the angiogenic effects of BMPs and CHL-1 using an in vitro angiogenesis assay (AngioKit, TCS Cellworks). Using 2 ng/ml VEGF and 20 muM Suramin as positive and negative controls, respectively, we successfully stimulated (p<0.001) and inhibited (p<0.001) angiogenesis (Figure 4A,D). While 10 ng/ml BMP-2 appeared to negatively regulate angiogenesis, this effect was not significant; however, 10 ng/ml BMP-4 significantly inhibited angiogenesis (p=0.0015; Figure 5B,D). CHL-1 alone had no effect on angiogenesis; however, it reversed the inhibitory effect of BMP-4 (Figure 4C,D).
###end p 61
###begin p 62
###xml 510 511 510 511 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 724 725 724 725 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 865 868 865 868 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-C</bold>
###xml 936 939 936 939 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-C</bold>
###xml 941 942 941 942 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 84 89 <span type="species:ncbi:9606">Human</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 350 355 <span type="species:ncbi:9606">human</span>
Chordin-like 1 modulates the antiangiogenic effect of bone morphogenetic protein-4. Human umbilical vascular endothelial cells(HUVECs) and human diploid fibroblasts were obtained (day 1) as cocultures in 24 well plates. Medium, with treatments or vehicle, was replenished on days 1, 4, 7, and 9. The assay was treated with VEGF, Suramin, recombinant human BMP-2, BMP-4, and CHL-1. Tubule formation was examined at day 11. Cells were fixed, quantitated, and visualized using a combined ELISA and histology kit. A: VEGF (2 ng/ml) and Suramin (20 mM) were used as positive and negative angiogenesis controls, respectively. B: Cells were treated with rhBMP-2 and rhBMP-4. BMP-4 significantly inhibited angiogenesis at 10 ng/ml. C: CHL-1 inhibited BMP-4; CHL-1 alone had no significant effect on angiogenesis, however it inhibited BMP-4s anti-angiogenic effects. Images A-C are shown at magnification 10X. Representative images are shown in A-C. D: Angiogenesis was quantitated by using anti-CD31 antibody coupled to a soluble substrate, rho-nitrophenol phosphate (rho-NPP), which permits quantitation by an optical density measurement. The asterisk indicates a significance at p<0.05 and the double asterisk indicates a significance at p<0.001.
###end p 62
###begin p 63
###xml 544 545 544 545 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 765 766 765 766 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 94 99 <span type="species:ncbi:9606">Human</span>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 402 407 <span type="species:ncbi:9606">human</span>
Vascular endothelial growth factor and bone morphogenetic protein-4 co-regulate angiogenesis. Human umbilical vascular endothelial cells (HUVECs) and human diploid fibroblasts were obtained (day 1) as cocultures in 24 well plates. Medium, with treatments or vehicle, was replenished on days 1, 4, 7, and 9. The assay was treated with vascular endothelial growth factor (VEGF), Suramin, and recombinant human BMP-4. Tubule formation was examined at day 11. Cells were fixed, quantitated, and visualized using a combined ELISA and histology kit. A: Angiogenesis assay demonstrating the combined effects of VEGF (pro-angiogenic) and BMP-4 (anti-angiogenic) on angiogenesis. Suramin was used as a negative control. (magnification 10X). Representative images are shown. B: Angiogenesis was quantitated by using anti-CD31 antibody coupled to a soluble substrate, rho-nitrophenol phosphate (rho-NPP), which permits quantitation by an optical density measurement. Data are expressed as mean+/-SEM values. The asterisk indicates a significance at p<0.01 and the double asterisk indicates a significance at p<0.001.
###end p 63
###begin title 64
Vascular endothelial growth factor and bone morphogenetic protein-4 co-regulate angiogenesis
###end title 64
###begin p 65
###xml 338 346 338 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
To examine whether the pro- and anti-angiogenic effects of VEGF and BMP-4 were mutually exclusive, we used these growth factors alone and in combination in an angiogenesis assay. We found 2 ng/ml VEGF stimulated angiogenesis and 10 ng/ml BMP-4 inhibited angiogenesis. In combination the two growth factors have no effect on angiogenesis (Figure 5).
###end p 65
###begin title 66
Discussion
###end title 66
###begin p 67
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 777 781 777 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 794 798 794 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cox2</italic>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 818 823 818 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 895 896 895 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 216 224 <span type="species:ncbi:9606">patients</span>
###xml 433 438 <span type="species:ncbi:9606">human</span>
The pathologic aberrations associated with diabetic retinopathy are localized primarily in the retinal capillaries. Pericyte loss and microaneurysm formation are hallmarks of early changes in the retinas of diabetic patients [23]. Retinal pericytes have been demonstrated to be involved in the regulation of endothelial cell number and morphology and microvessel architecture [8]. We have investigated the transcriptomic response of human retinal pericytes to hypoxic insult. Over three biologic replicate experiments, 35 genes (28 upregulated and seven downregulated) demonstrated differential expression after 48 h exposure to hypoxia. Among the upregulated genes were those whose expression has previously been associated with both hypoxia and diabetic retinopathy, such as VEGF [24-27] and Cox2 [18,28]. One gene, CHL-1/ventroptin has been described in the context of the developing retina [9]; however, its regulation or an association with a disease process is yet to be described.
###end p 67
###begin p 68
###xml 334 339 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 571 575 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 577 581 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cox2</italic>
###xml 587 592 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
HIF-1alpha is a transcription factor implicated in hypoxia-elicited transcription. It binds HRE, a consensus element within promoters. We examined the promoters of the upregulated genes for the presence of the HIF-1alpha binding site (data not shown) and found 18 of the 27 upregulated genes contained HIF binding elements, including CHL-1. We also demonstrated increased nuclear presence of HIF-1alpha over a timecourse of exposure to hypoxia. Overexpression of HIF-1alpha drove the expression of many of the genes with HRE binding sites within their promoters, such as VEGF, Cox2, and CHL-1.
###end p 68
###begin p 69
###xml 379 384 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 409 414 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
###xml 637 641 625 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 833 835 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 870 875 858 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHL-1</italic>
Our data demonstrate that CHL-1 (Ventroptin, Neuralin-1), a BMP antagonist, is expressed by retinal pericytes in response to hypoxic insult. Its promoter contains binding sites for many transcription factors, including the known hypoxia responsive transcription factors HIF-1alpha and cyclic AMP response element-binding protein (CREB; data not shown). We have demonstrated that CHL-1 mRNA expression and the CHL-1 promoter is driven by hypoxia and by overexpressing HIF-1alpha. This suggests that HIF-1alpha contributes to the expression of CHL-1 in a hypoxic environment. Another possible regulator of CHL-1 expression may be VEGF, as VEGF mRNA is upregulated by hypoxia by 6h, it is possible it contributes to the upregulation of CHL-1 expression by 24h, as activation of the VEGF receptors activates multiple signaling pathways [29]and the precise regulation of the CHL-1 promoter has yet to be defined.
###end p 69
###begin p 70
###xml 64 65 64 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 886 888 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1186 1188 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1355 1357 1355 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 1399 1401 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1495 1497 1495 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 1498 1500 1498 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 1739 1741 1739 1741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 1742 1744 1742 1744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 2027 2028 2023 2024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 2089 2093 2085 2089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 2095 2097 2091 2093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 2098 2100 2094 2096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 2130 2132 2126 2128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 2395 2397 2391 2393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 3522 3524 3518 3520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 1050 1055 <span type="species:ncbi:9606">human</span>
CHL-1 is a secreted protein expressed in the developing retina [9]. CHL-1 has three cysteine rich repeats (CRs). CRs are characteristic motifs that are conserved in some proteins including von Willebrand factor and chordin as well as other extracellular proteins, of which several are involved in regulation of BMP signaling regulation [30]. Because the three CRs of CHL-1 were significantly homologous to Chordin, Sakuta et al. [9] hypothesized and demonstrated that ventroptin (CHL-1) binds to and inhibits BMP-4. Another study demonstrated that ventroptin also inhibits BMP-2 [20]. This adds CHL-1 to a growing family of secretory proteins that antagonize BMPs, including chordin, Noggin, Cerberus, DAN, and Gremlin [31-34]. We have previously shown the BMP antagonist Gremlin to be upregulated in diabetic nephropathy [35,36] and localized to the outer retina of STZ diabetic mice [37]. Both BMP-2 and BMP-4 have been previously demonstrated to act as negative growth regulators in the retinal pigmented epithelium (RPE) [21]. We have found that human retinal pericytes express both BMP-2 and BMP-4. Other reports have shown decreases in BMP-4 in the retina in response to hypoxia [21]; however, in our study BMP-4 mRNA levels in retinal pericytes were unaffected by hypoxia. BMP-4 itself has been shown to promote apoptosis in the developing retina [38] and play a role in capillary apoptosis [22]. BMPs have also been demonstrated to stimulate angiogenesis through the production of VEGF [10,39]. We have shown that retinal pericytes not only express and secrete both BMP-2 and BMP-4, but they also secrete CHL-1 in response to hypoxic stimulus. Hypoxia is a well documented stimulus for angiogenesis and retinal neovascularization [40,41]. We have demonstrated here that hypoxia-induced HIF-1alpha drives CHL-1 expression in retinal pericytes, and that expressed recombinant V5-tagged CHL-1 binds BMP-4. Binding of CHL-1 to members of the BMP family has been previously demonstrated to modulate the function of the BMP [9]. Two studies showed regulation of angiogenesis by BMPs via VEGF [10,39]. More recently Vogt et al. [42] demonstrated that stimulation of ARPE-19 cells with BMP-4 results in increased VEGF expression. It has been documented that VEGFs secreted by epithelia, including the RPE, are likely to mediate paracrine vascular signals for adjacent endothelial (discussed in [43]). BMP-4 expression in the retina may have different effects on different cell types, such as increased VEGF expression from RPE cells and an anti-angiogenic effect on endothelial cells. In this study we demonstrated direct modulation of angiogenesis by BMP-4 in an in vitro angiogenesis assay and that this inhibition is modulated by the addition of CHL-1. We have also demonstrated that CHL-1 binds to BMP-4 and suggest that this binding prevents BMP-4 from acting at its receptor. Therefore, BMP-4 may play a role in the retina in maintaining capillary endothelial cell number, and the modulation of endogenous BMP levels in the retina may play a role in the plasticity of the retinal microvasculature in disease states. Induction of a BMP antagonist, namely CHL-1, by ischemic insult in a pathologic setting may function to neutralize BMP action on endothelial cells. Specifically, modulation of local BMP-4 activity in maintenance of capillary cell number by CHL-1, in response to a hypoxic environment, may contribute to retinal neovascularization, by allowing proliferation of endothelial cells. Gariano and Gardner [44] recently reviewed retinal angiogenesis and affirmed that pathological retinal neovascularization in the diabetic retina results from an imbalance of pro-angiogenic and anti-angiogenic factors. We have demonstrated in this study that angiogenic homeostasis may be maintained by such a combination, namely VEGF and BMP-4. We suggest that the balance between BMP-4 and VEGF is crucial in maintaining angiogenic homeostasis, and that the inhibition of the anti-angiogenic factor, BMP-4, by CHL-1, along with increases in VEGF tilt the balance in favor of a pro-angiogenic retinal environment.
###end p 70
###begin title 71
Acknowledgments
###end title 71
###begin p 72
R.K. is the recipient of a Health Research Board, Ireland, Post-Doctoral Fellowship. Work in the author's laboratory is supported by Science Foundation Ireland, the Health Research Board, EU FP6 EICOSANOX consortium (LSHM-CT-2004-005033), and The Government of Ireland's Programme for Research in Third Level Institutions (PRTLI) of the Higher Education Authority. We thank Dr. Cormac Taylor and Dr. Martin Leonard for helpful discussions and Catherine Moss for technical assistance.The accession numbers associated with the sequences in this study are  and .
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
The Prevalence of Diabetic Retinopathy Among Adults in the United States.
###end article-title 74
###begin article-title 75
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
###end article-title 75
###begin article-title 76
Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.
###end article-title 76
###begin article-title 77
Microvascular pericytes: a review of their morphological and functional characteristics.
###end article-title 77
###begin article-title 78
Microvascular pericytes contain muscle and nonmuscle actins.
###end article-title 78
###begin article-title 79
Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells.
###end article-title 79
###begin article-title 80
###xml 51 57 <span type="species:ncbi:9913">bovine</span>
Modulation of extracellular matrix biosynthesis by bovine retinal pericytes in vitro: effects of the substratum and cell density.
###end article-title 80
###begin article-title 81
Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis.
###end article-title 81
###begin article-title 82
Iemura Si, Yamamoto TS, Ueno N, Noda M. Ventroptin: A BMP-4 Antagonist Expressed in a Double-Gradient Pattern in the Retina.
###end article-title 82
###begin article-title 83
Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A.
###end article-title 83
###begin article-title 84
Independent function of two destruction domains in hypoxia-inducible factor-{alpha} chains activated by prolyl hydroxylation.
###end article-title 84
###begin article-title 85
Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1{alpha}.
###end article-title 85
###begin article-title 86
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Neuralin-1 is a novel Chordin-related molecule expressed in the mouse neural plate.
###end article-title 86
###begin article-title 87
A Novel Chordin-like Protein Inhibitor for Bone Morphogenetic Proteins Expressed Preferentially in Mesenchymal Cell Lineages.
###end article-title 87
###begin article-title 88
Hypoxic regulation of vascular endothelial growth factor in retinal cells.
###end article-title 88
###begin article-title 89
###xml 47 52 <span type="species:ncbi:10090">Mouse</span>
COX-2 Inhibition and Retinal Angiogenesis in a Mouse Model of Retinopathy of Prematurity.
###end article-title 89
###begin article-title 90
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
COX-2 protects against thrombosis of the retinal vasculature in a mouse model of proliferative retinopathy.
###end article-title 90
###begin article-title 91
CBF1 controls the retinotectal topographical map along the anteroposterior axis through multiple mechanisms.
###end article-title 91
###begin article-title 92
Bone Morphogenetic Proteins-2 and -4: Negative Growth Regulators in Adult Retinal Pigmented Epithelium.
###end article-title 92
###begin article-title 93
###xml 86 89 <span type="species:ncbi:10116">Rat</span>
Bone Morphogenetic Protein 4 Mediates Apoptosis of Capillary Endothelial Cells during Rat Pupillary Membrane Regression.
###end article-title 93
###begin article-title 94
Retinal vascular pattern. IV. Diabetic retinopathy.
###end article-title 94
###begin article-title 95
###xml 54 62 <span type="species:ncbi:9606">Patients</span>
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders.
###end article-title 95
###begin article-title 96
Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1.
###end article-title 96
###begin article-title 97
###xml 34 37 <span type="species:ncbi:10116">Rat</span>
Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia.
###end article-title 97
###begin article-title 98
###xml 85 90 <span type="species:ncbi:9606">Human</span>
Synergistic Cooperation between Hypoxia and Transforming Growth Factor-b Pathways on Human Vascular Endothelial Growth Factor Gene Expression.
###end article-title 98
###begin article-title 99
###xml 80 85 <span type="species:ncbi:9606">Human</span>
Hypoxia Induces Cyclooxygenase-2 via the NF-kappa B p65 Transcription Factor in Human Vascular Endothelial Cells.
###end article-title 99
###begin article-title 100
The role of VEGF receptors in angiogenesis; complex partnerships
###end article-title 100
###begin article-title 101
Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems.
###end article-title 101
###begin article-title 102
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine Cerberus Homologue mCer-1: A Candidate Anterior Patterning Molecule.
###end article-title 102
###begin article-title 103
###xml 4 11 <span type="species:ncbi:8355">Xenopus</span>
The Xenopus Dorsalizing Factor Gremlin Identifies a Novel Family of Secreted Proteins that Antagonize BMP Activities.
###end article-title 103
###begin article-title 104
###xml 2 7 <span type="species:ncbi:10090">Mouse</span>
A Mouse Cerberus/Dan-Related Gene Family.
###end article-title 104
###begin article-title 105
Cerberus regulates left-right asymmetry of the embryonic head and heart.
###end article-title 105
###begin article-title 106
###xml 57 62 <span type="species:ncbi:9606">human</span>
IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta 1.
###end article-title 106
###begin article-title 107
###xml 56 61 <span type="species:ncbi:9606">Human</span>
of Gremlin, a Bone Morphogenetic Protein Antagonist, in Human Diabetic Nephropathy.
###end article-title 107
###begin article-title 108
###xml 27 33 <span type="species:ncbi:9913">bovine</span>
Gremlin gene expression in bovine retinal pericytes exposed to elevated glucose.
###end article-title 108
###begin article-title 109
###xml 53 58 <span type="species:ncbi:9031">Chick</span>
BMP4 Mediates Apoptotic Cell Death in the Developing Chick Eye.
###end article-title 109
###begin article-title 110
###xml 87 96 <span type="species:ncbi:7955">zebrafish</span>
Transcription regulation of the vegf gene by the BMP/Smad pathway in the angioblast of zebrafish embryos.
###end article-title 110
###begin article-title 111
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.
###end article-title 111
###begin article-title 112
Hypoxia inducible factor-1alpha is increased in
###end article-title 112
###begin article-title 113
###xml 86 91 <span type="species:ncbi:9606">human</span>
Bone morphogenetic protein-4 enhances vascular endothelial growth factor secretion by human retinal pigment epithelial cells.
###end article-title 113
###begin article-title 114
Vascular endothelial growth factors and angiogenesis in eye disease.
###end article-title 114
###begin article-title 115
Retinal angiogenesis in development and disease.
###end article-title 115

